cell therapy

Read More
Immunai co-founders (from left) Luis Voloch and Noam Solomon

Israel’s Immunai first to map whole immune system, scores $20m. investment

Immunai says it has mapped out millions of immune cells and their functions that could help detect, diagnose and treat cancer and many other diseases.

Israeli cell therapy company offers solution after failed Russian experiment

Radiation poisoning, known in the medical world as acute radiation syndrome or ARS, is a grave illness that often leads to death.

Pluristem gets positive results from radiation treatment trials

“We believe that this outcome is an important contribution to protect the armed and medical forces which may need to enter contaminated areas,” Chief Executive Officer Yaky Yanay said.

Ben-Gurion University of the Negev.

BGU researchers discover sense of ‘touch’ in blood cells

Lymphocytes found to differentiate healthy cells from sick ones through chemical and mechanical reactions

A Pluristem scientist in the process of making its cell products and a look at the final product its

USFDA clears Plursitem for expanded access program

Patients suffering from critical limb ischemia can now benefit without being part of clinical trials

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy